A leading global pharmaceutical services company has announced the appointment of a new Chief Executive Officer (CEO).
UK-headquartered Biotec Services International has promoted Dr Fiona Withey to the position of CEO.
Dr Withey joined Biotec's business development team in 2007 after gaining a PhD in Biochemical Engineering from Swansea University, which was followed by 12 years working in the pharmaceutical outsourcing sector.
In 2008, Dr Withey was appointed to the main board of directors as Business Development Director. She played an instrumental role in the company's management buy-out in 2010 and since February 2012, she has headed up the operations team as Operations Director during a period of very strong growth in the business.
Dr Withey will be responsible for commencing a new stage of Biotec's international development plan which includes expanding its US operation, continuing to develop its client base internationally and to build further on its position as a leading worldwide provider of temperature controlled pharmaceutical services.
Dr Withey replaces Keren Winmill who, after four years as CEO of Biotec, is moving to the role of Non-executive Director and Advisory Board Chair.
On her appointment, Dr Withey said: "I'm delighted to be taking over the reins as CEO. Keren has been an exceptional leader during the past four years; under her direction Biotec has become a world-renowned name for quality and flexibility in our industry. Today, our business supports more than 100 clinical and commercial projects for over 75 customers, across 60 countries. I'm very keen to build on this by continuing to develop the services for our existing customers and to grow more and more partnerships world-wide."
Keren Winmill, Former CEO, said: "Fiona has a trusted reputation across the pharmaceutical industry. She will ensure the company continues to bring a combination of client focus, operational discipline and strong leadership to the team, I am very proud of everything that the team has accomplished during the past four years and I very much look forward to working with Fiona and the team on the next stage."
Headquartered in South Wales, UK, Biotec Services International delivers efficient solutions for the packaging, distribution, transport and storage of temperature controlled pharmaceutical products including regenerative and cell-based therapies in over 60 countries, working with virtual right through to blue chip international pharmaceutical companies.
In recent years, Biotec has achieved impressive international growth, including in both the US and Israel. It has opened a new process-centric operations facility and the company was awarded the 'Best International Business in the UK' by the British Chamber of Commerce.
For media enquiries please contact Jodie Phillips or Lyndsey Jenkins at jamjar PR on 01446 771265/ 07809 330975 or email [email protected]
Notes to Editors
Biotec is a pharmaceutical services company established in 1997.
The company specialises in distributing clinical and commercial supplies over a wide range of temperatures, to countries worldwide.
Biotec's 25,000 sq. ft. facility is headquartered in Bridgend, Wales, UK with a staff count of 60.
Sales offices in USA and Israel
2013 turnover £9.4 mil